Mortality and Functionality after Stroke in Patients with Systemic Lupus Erythematosus

REFERENCES

1. 1.↵
   1. Arkema EV,
   2. Svenungsson E,
   3. Von Euler M,
   4. Sjowall C,
   5. Simard JF

   . Stroke in systemic lupus erythematosus: a Swedish population-based cohort study. Ann Rheum Dis 2017;76:1544–9.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Holmqvist M,
   2. Simard JF,
   3. Asplund K,
   4. Arkema EV

   . Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies. RMD Open 2015;1:e000168.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Elfving P,
   2. Puolakka K,
   3. Kautiainen H,
   4. Virta LJ,
   5. Pohjolainen T,
   6. Kaipiainen-Seppanen O

   . Mortality and causes of death among incident cases of systemic lupus erythematosus in Finland 2000–2008. Lupus 2014;23:1430–4.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Thomas G,
   2. Mancini J,
   3. Jourde-Chiche N,
   4. Sarlon G,
   5. Amoura Z,
   6. Harle JR,
   7. et al.

   Mortality associated with systemic lupus erythematosus in France assessed by multiple-cause-of-death analysis. Arthritis Rheumatol 2014;66:2503–11.

   OpenUrl
5. 5.↵
   1. Lerang K,
   2. Gilboe IM,
   3. Steinar Thelle D,
   4. Gran JT

   . Mortality and years of potential life loss in systemic lupus erythematosus: a population-based cohort study. Lupus 2014;23:1546–52.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Svenungsson E,
   2. Gustafsson J,
   3. Leonard D,
   4. Sandling J,
   5. Gunnarsson I,
   6. Nordmark G,
   7. et al.

   A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus. Ann Rheum Dis 2010;69:834–40.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Bertsias GK,
   2. Boumpas DT

   . Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations. Nat Rev Rheumatol 2010;6:358–67.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Timlin H,
   2. Petri M

   . Transient ischemic attack and stroke in systemic lupus erythematosus. Lupus 2013;22:1251–8.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Bernatsky S,
   2. Clarke A,
   3. Gladman DD,
   4. Urowitz M,
   5. Fortin PR,
   6. Barr SG,
   7. et al.

   Mortality related to cerebrovascular disease in systemic lupus erythematosus. Lupus 2006;15:835–9.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Krishnan E

    . Stroke subtypes among young patients with systemic lupus erythematosus. Am J Med 2005;118:1415.

    OpenUrlPubMed
11. 11.↵
    1. Ward MM

    . Outcomes of hospitalizations for myocardial infarctions and cerebrovascular accidents in patients with systemic lupus erythematosus. Arthritis Rheum 2004;50:3170–6.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Nguyen-Oghalai TU,
    2. Wu H,
    3. McNearney TA,
    4. Granger CV,
    5. Ottenbacher KJ

    . Functional outcome after stroke in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 2008;59:984–8.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Ludvigsson JF,
    2. Andersson E,
    3. Ekbom A,
    4. Feychting M,
    5. Kim JL,
    6. Reuterwall C,
    7. et al.

    External review and validation of the Swedish national inpatient register. BMC Public Health 2011;11:450.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Arkema EV,
    2. Jonsen A,
    3. Ronnblom L,
    4. Svenungsson E,
    5. Sjowall C,
    6. Simard JF

    . Case definitions in Swedish register data to identify systemic lupus erythematosus. BMJ Open 2016;6:e007769.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Asplund K,
    2. Hulter Åsberg K,
    3. Appelros P,
    4. Bjarne D,
    5. Eriksson M,
    6. Johansson A,
    7. et al.

    The Riks-Stroke story: building a sustainable national register for quality assessment of stroke care. Int J Stroke 2011;6:99–108.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Arkema EV,
    2. Simard JF

    . Cohort profile: systemic lupus erythematosus in Sweden: the Swedish Lupus Linkage (SLINK) cohort. BMJ Open 2015;5:e008259.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Riksstroke Collaboration

    . Riksstroke forms. [Internet. Accessed August 15, 2017.] Available from: www.riksstroke.org/forms/
18. 18.↵
    1. Starmark JE,
    2. Stålhammar D,
    3. Holmgren E

    . The Reaction Level Scale (RLS85). Manual and guidelines. Acta Neurochir 1988;91:12–20.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Cole SR,
    2. Hernan MA

    . Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed 2004;75:45–9.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Royston P,
    2. Lambert PC

    . Flexible parametric survival analysis using stata: beyond the Cox model. College Station, TX: Stata Press; 2011.
21. 21.↵
    1. Zou G

    . A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004;159:702–6.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Gustafsson JT,
    2. Simard JF,
    3. Gunnarsson I,
    4. Elvin K,
    5. Lundberg IE,
    6. Hansson LO,
    7. et al.

    Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study. Arthritis Res Ther 2012;14:R46.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Bernatsky S,
    2. Boivin JF,
    3. Joseph L,
    4. Manzi S,
    5. Ginzler E,
    6. Gladman DD,
    7. et al.

    Mortality in systemic lupus erythematosus. Arthritis Rheum 2006;54:2550–7.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Appelros P,
    2. Jonsson F,
    3. Åsberg S,
    4. Asplund K,
    5. Glader EL,
    6. Åsberg KH,
    7. et al.

    Trends in stroke treatment and outcome between 1995 and 2010: observations from Riks-Stroke, the Swedish stroke register. Cerebrovasc Dis 2014;37:22–9.

    OpenUrlCrossRefPubMed